Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials.

TG and liver function We observed a significant change in TG: k=74, d=−5.40 mg/dL (95% CI −9.17 to −1.63; I2=35.9%), ALAT: k=26, d=−4.40 U/L (95% CI −7.58 to −1.22; I2=92.9%) and ASAT: k=23, d=−3.67 U/L (95% CI −7.25 to −0.09; I2=96.8%) as well as a borderline significant trend in GGT: k=14, d=−3.14 U/L (95% CI −6.60 to 0.33; I2=86.9%) with high heterogeneity ( figure 2C , see online supplementary figures 45–56 ).

also in 231 other papers